Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian O Kim

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
JAMA Network Open|September 5, 2023
New Cancer Diagnoses Before and During the COVID-19 PandemicKathleen M Decker, Allison Feely, Oliver Bucher, et al.
Technology in Cancer Research & Treatment|July 25, 2024
Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, CanadaKathleen M Decker, Grace Musto, Oliver Bucher, et al.
Current Oncology (Toronto, Ont.)|August 26, 2021
Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in ManitobaKathleen M Decker, Pascal Lambert, Allison Feely, et al.
Journal of Cancer Policy|March 13, 2025
Measuring the impact of COVID-19 on time to treatment for individuals diagnosed with cancer in Manitoba, Canada using an interrupted time series analysisPascal Lambert, Katie Galloway, Allison Feely, et al.
JNCI Cancer Spectrum|January 4, 2024
Measuring the impact of COVID-19 on cancer survival using an interrupted time series analysisPascal Lambert, Katie Galloway, Allison Feely, et al.
American Journal of Clinical Oncology|September 25, 2020
Population-based Assessment of Intermittent Androgen Deprivation Therapy Utilization for Relapsed, Nonmetastatic, Hormone-sensitive Adenocarcinoma of the ProstateBryan W Janzen, Aldrich Ong, Makoy Penner, et al.
JCO Clinical Cancer Informatics|October 30, 2025
Measuring the Association Between the COVID-19 Pandemic and Cancer Incidence by Sex Using a Quasi-Experimental Study DesignKathleen M Decker, Allison Feely, Iresha Ratnayake, et al.
Cancer Medicine|November 17, 2023
Cancer incidence during the COVID-19 pandemic by region of residence in Manitoba, Canada: A cancer registry-based interrupted time series studyKathleen M Decker, Allison Feely, Oliver Bucher, et al.
Cancer & Metabolism|October 12, 2022
Data-driven identification of plasma metabolite clusters and metabolites of interest for potential detection of early-stage non-small cell lung cancer cases versus cancer-free controlsJulian O Kim, Robert Balshaw, Connel Trevena, et al.
Frontiers in Oncology|October 5, 2023
Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort studyDavid E Dawe, Rebekah Rittberg, Iqra Syed, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
JAMA Network Open|September 5, 2023
New Cancer Diagnoses Before and During the COVID-19 PandemicKathleen M Decker, Allison Feely, Oliver Bucher, et al.
Technology in Cancer Research & Treatment|July 25, 2024
Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, CanadaKathleen M Decker, Grace Musto, Oliver Bucher, et al.
Current Oncology (Toronto, Ont.)|August 26, 2021
Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in ManitobaKathleen M Decker, Pascal Lambert, Allison Feely, et al.
Journal of Cancer Policy|March 13, 2025
Measuring the impact of COVID-19 on time to treatment for individuals diagnosed with cancer in Manitoba, Canada using an interrupted time series analysisPascal Lambert, Katie Galloway, Allison Feely, et al.
JNCI Cancer Spectrum|January 4, 2024
Measuring the impact of COVID-19 on cancer survival using an interrupted time series analysisPascal Lambert, Katie Galloway, Allison Feely, et al.
American Journal of Clinical Oncology|September 25, 2020
Population-based Assessment of Intermittent Androgen Deprivation Therapy Utilization for Relapsed, Nonmetastatic, Hormone-sensitive Adenocarcinoma of the ProstateBryan W Janzen, Aldrich Ong, Makoy Penner, et al.
JCO Clinical Cancer Informatics|October 30, 2025
Measuring the Association Between the COVID-19 Pandemic and Cancer Incidence by Sex Using a Quasi-Experimental Study DesignKathleen M Decker, Allison Feely, Iresha Ratnayake, et al.
Cancer Medicine|November 17, 2023
Cancer incidence during the COVID-19 pandemic by region of residence in Manitoba, Canada: A cancer registry-based interrupted time series studyKathleen M Decker, Allison Feely, Oliver Bucher, et al.
Cancer & Metabolism|October 12, 2022
Data-driven identification of plasma metabolite clusters and metabolites of interest for potential detection of early-stage non-small cell lung cancer cases versus cancer-free controlsJulian O Kim, Robert Balshaw, Connel Trevena, et al.
Frontiers in Oncology|October 5, 2023
Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort studyDavid E Dawe, Rebekah Rittberg, Iqra Syed, et al.
Pageof 4